# Correction: Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography

**Authors:** Shinsuke Uchikawa, Tomokazu Kawaoka, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Daiki Miki, Michio Imamura, Hiroshi Aikata

PMC · DOI: 10.1007/s10396-024-01430-2 · Journal of Medical Ultrasonics (2001) · 2024-03-11

## Full-text entities

- **Diseases:** hepatocellular carcinoma (MESH:D006528)
- **Chemicals:** atezolizumab (MESH:C000594389), bevacizumab (MESH:D000068258)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11098856/full.md

---
Source: https://tomesphere.com/paper/PMC11098856